National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meetings, 49181-49182 [2024-12733]
Download as PDF
Federal Register / Vol. 89, No. 113 / Tuesday, June 11, 2024 / Notices
[FR Doc. 2024–12683 Filed 6–10–24; 8:45 am]
Dated: June 6, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
BILLING CODE 4150–04–P
[FR Doc. 2024–12736 Filed 6–10–24; 8:45 am]
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer Institute
Council of Research Advocates.
The meeting will be held as a virtual
meeting and will be open to the public
as indicated below. Individuals who
plan to view the virtual meeting and
need special assistance or other
reasonable accommodations to view the
meeting, should notify the Contact
Person listed below in advance of the
meeting. The meeting can be accessed
from the NIH Videocast at the following
link: https://videocast.nih.gov/.
Name of Committee: National Cancer
Institute Council of Research Advocates
(NCRA).
Date: June 26, 2024.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: Welcome and Chairwoman’s
Remarks, NCI Director’s Update, NCI
Updates, and Legislative Update.
Place: National Institutes of Health,
Building 31, 9000 Rockville Pike, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Amy Williams, Director,
NCI Office of Advocacy Relations, National
Cancer Institute, NIH, 31 Center Drive,
Building 31, Room 10A28, Bethesda, MD
20892, (301) 496–9723, williaam@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/ncra/ncra.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
17:09 Jun 10, 2024
Jkt 262001
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 6, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–12734 Filed 6–10–24; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
49181
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Center for Scientific Review; Notice of
Closed Meetings
National Institutes of Health
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Understanding Neurobiology of Aging and
Neurodegeneration.
Date: July 9, 2024.
Time: 9:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Wei-Qin Zhao, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5181,
MSC 7846, Bethesda, MD 20892–7846, 301–
827–7238, zhaow@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
conflict: Topics on Biobehavioral Processes.
Date: July 9–10, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Aruna K Behera, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4211,
MSC 7814, Bethesda, MD 20892, (301) 435–
6809, beheraak@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Special Emphasis
Panel for Member Conflict Applications.
Date: July 1, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Luis Espinoza, Ph.D.,
Scientific Review Officer, Extramural Project
Review Branch, Office of Extramural
Activities, National Institute on Alcohol
Abuse and Alcoholism, National Institutes of
Health, 6700B Rockledge Drive, Room 2109,
Bethesda, MD 20892, (301) 443–8599,
espinozala@mail.nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Fellowship Review
Panel.
Date: July 9, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Luis Espinoza, Ph.D.,
Scientific Review Officer, Extramural Project
Review Branch, Office of Extramural
Activities, National Institute on Alcohol
E:\FR\FM\11JNN1.SGM
11JNN1
khammond on DSKJM1Z7X2PROD with NOTICES
49182
Federal Register / Vol. 89, No. 113 / Tuesday, June 11, 2024 / Notices
Abuse and Alcoholism, National Institutes of
Health, 6700B Rockledge Drive, Room 2109,
Bethesda, MD 20892, (301) 443–8599,
espinozala@mail.nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; RFA AA–24–004 and 005—
Limited Competition: Alcohol-associated
Hepatitis Clinical Network—Integrated
Treatment Clinical Trials.
Date: July 19, 2024.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch,
National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health,
6700B Rockledge Drive, Room 2114,
Bethesda, MD 20892, (301) 451–2067,
srinivar@mail.nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; RFA–AA–23–004—
Comprehensive Alcohol-HIV/AIDS Research
Center (P60 Clinical Trial Optional).
Date: July 23–24, 2024.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch,
National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health,
6700B Rockledge Drive, Room 2114,
Bethesda, MD 20892, (301) 451–2067,
srinivar@mail.nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; RFA AA–24–002 HighThroughput Screening Platform for Discovery
of and PAR–22–103 Investigational New
Drug (IND)-enabling and Early-Stage
Development of Medications to Treat Alcohol
Use disorder and Alcohol-Associated Organ
Damage (UT1/UT2)
Date: July 25, 2024.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Luis Espinoza, Ph.D.,
Scientific Review Officer, Extramural Project
Review Branch, Office of Extramural
Activities, National Institute on Alcohol
Abuse and Alcoholism, National Institutes of
Health, 6700B Rockledge Drive, Room 2109,
Bethesda, MD 20892, (301) 443–8599,
espinozala@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.273, Alcohol Research
Programs, National Institutes of Health, HHS)
VerDate Sep<11>2014
17:09 Jun 10, 2024
Jkt 262001
Dated: June 6, 2024.
David W Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–12733 Filed 6–10–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–7084–N–04]
60-Day Notice of Proposed Information
Collection: Semi-Annual Labor
Standards Enforcement Report—Local
Contracting Agencies (HUD Program);
OMB Control No.: 2501–0019
Office of Field Policy and
Management, Housing and Urban
Development (HUD).
ACTION: Notice.
AGENCY:
HUD is seeking approval from
the Office of Management and Budget
(OMB) for the information collection
described below. In accordance with the
Paperwork Reduction Act, HUD is
requesting comment from all interested
parties on the proposed collection of
information. The purpose of this notice
is to allow for 60 days of public
comment.
DATES: Comments Due Date: August 12,
2024.
ADDRESSES: Interested persons are
invited to submit comments regarding
this proposal. Written comments and
recommendations for the proposed
information collection can be sent
within 60 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 60-day Review—Open
for Public Comments’’ or by using the
search function. Interested persons are
also invited to submit comments
regarding this proposal and comments
should refer to the proposal by name
and/or OMB Control Number and
should be sent to: Jennifer A. Dupont,
Program Analyst, Office of Field Policy
and Management, Department of
Housing and Urban Development, 40
Marietta Street, 10th Floor, Atlanta, GA
30303 or the number (678) 732–2034
this is not a toll free number or email
at Jennifer.A.Dupont@hud.gov for a
copy of the proposed forms or other
available information.
FOR FURTHER INFORMATION CONTACT:
Colette Pollards, Reports Management
Officer, QDAM, Department of Housing
and Urban Development, 451 7th Street
SW, Washington, DC 20410, telephone
(202) 402–3400 (this is not a toll free
number) or email Colette Pollard at
SUMMARY:
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Colette.Pollard@hud.gov for copies of
the proposed forms and other available
information. HUD welcomes and is
prepared to receive calls from
individuals who are deaf or hard of
hearing, as well as individuals with
speech or communication disabilities.
To learn more about how to make an
accessible telephone call, please visit
https://www.fcc.gov/consumers/guides/
telecommunications-relay-service-trs.
SUPPLEMENTARY INFORMATION: The
Department is submitting the proposed
information collection to OMB for
review, as required by the Paperwork
Reduction Act of 1995 (44 U.S.C.
chapter 35, as amended).
This Notice is soliciting comments
from members of the public and affected
agencies concerning the proposed
collection of information to: (1) Evaluate
whether the proposed collection is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information; (3) Enhance the quality,
utility, and clarity of the information to
be collected; and (4) Minimize the
burden of the collection of information
on those who are to respond; including
the use of appropriate automated
collection techniques or other forms of
information technology, e.g., permitting
electronic submission of responses.
This Notice also lists the following
information:
Title of Information Collection: SemiAnnual Labor Standards Enforcement
Report—Local Contracting Agencies
(HUD Programs).
OMB Control Number, if applicable:
2501–0019.
Description of the need for the
information and proposed use: The
Department of Labor (DOL) requires all
Federal agencies administering
programs subject to Davis-Bacon wage
requirements covered by 29 CFR 5.7(b)
to submit a semi-annual report of all
new covered contracts/projects and all
enforcement activities during the sixmonth reporting period. For HUD to
comply, HUD collects data from state
and local agencies that administer HUDassisted programs subject to DavisBacon requirements. HUD requires these
agencies to complete and submit a
Semi-annual Labor Standards
Enforcement Report every six months.
Respondents and HUD must retain a
copy of the Semi-annual Labor
Standards Enforcement Report files at
least three years.
Agency form numbers, if applicable:
HUD FORM 4710.
E:\FR\FM\11JNN1.SGM
11JNN1
Agencies
[Federal Register Volume 89, Number 113 (Tuesday, June 11, 2024)]
[Notices]
[Pages 49181-49182]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-12733]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of
Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Special Emphasis Panel; NIAAA Special Emphasis Panel for
Member Conflict Applications.
Date: July 1, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Luis Espinoza, Ph.D., Scientific Review Officer,
Extramural Project Review Branch, Office of Extramural Activities,
National Institute on Alcohol Abuse and Alcoholism, National
Institutes of Health, 6700B Rockledge Drive, Room 2109, Bethesda, MD
20892, (301) 443-8599, [email protected].
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Special Emphasis Panel; NIAAA Fellowship Review Panel.
Date: July 9, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Luis Espinoza, Ph.D., Scientific Review Officer,
Extramural Project Review Branch, Office of Extramural Activities,
National Institute on Alcohol
[[Page 49182]]
Abuse and Alcoholism, National Institutes of Health, 6700B Rockledge
Drive, Room 2109, Bethesda, MD 20892, (301) 443-8599,
[email protected].
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Special Emphasis Panel; RFA AA-24-004 and 005--Limited
Competition: Alcohol-associated Hepatitis Clinical Network--
Integrated Treatment Clinical Trials.
Date: July 19, 2024.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Ranga Srinivas, Ph.D., Chief, Extramural Project
Review Branch, National Institute on Alcohol Abuse and Alcoholism,
National Institutes of Health, 6700B Rockledge Drive, Room 2114,
Bethesda, MD 20892, (301) 451-2067, [email protected].
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Special Emphasis Panel; RFA-AA-23-004--Comprehensive
Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional).
Date: July 23-24, 2024.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Ranga Srinivas, Ph.D., Chief, Extramural Project
Review Branch, National Institute on Alcohol Abuse and Alcoholism,
National Institutes of Health, 6700B Rockledge Drive, Room 2114,
Bethesda, MD 20892, (301) 451-2067, [email protected].
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Special Emphasis Panel; RFA AA-24-002 High-Throughput
Screening Platform for Discovery of and PAR-22-103 Investigational
New Drug (IND)-enabling and Early-Stage Development of Medications
to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage
(UT1/UT2)
Date: July 25, 2024.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Luis Espinoza, Ph.D., Scientific Review Officer,
Extramural Project Review Branch, Office of Extramural Activities,
National Institute on Alcohol Abuse and Alcoholism, National
Institutes of Health, 6700B Rockledge Drive, Room 2109, Bethesda, MD
20892, (301) 443-8599, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.273,
Alcohol Research Programs, National Institutes of Health, HHS)
Dated: June 6, 2024.
David W Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-12733 Filed 6-10-24; 8:45 am]
BILLING CODE 4140-01-P